Overview

Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the study is to explore if chlorogenic acid is safe in patients with cancer.
Phase:
Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Chinese Academy of Medical Sciences
Collaborator:
Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd
Criteria
Inclusion Criteria:

- advanced cancer with no effective treatment

- Karnofsky performance status no less than 70

- adequated organ function

- informed consent

Exclusion Criteria:

- allergic to chlorogenic acid

- persistent toxicities from previous treatment (no less than grade 2)